<DOC>
	<DOC>NCT01660295</DOC>
	<brief_summary>This study will assess the pharmacokinetics in subjects with severe renal insufficiency and healthy subjects.</brief_summary>
	<brief_title>Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<criteria>Inclusion criteria: Healthy subjects OR Subjects with severe renal insufficiency Exclusion criteria: Hypersensitivity to study medication Genetic abnormality or disease of clotting system Prior major surgery or bleeding Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Severe renal insufficiency certoparin</keyword>
	<keyword>Severe renal insufficiency</keyword>
</DOC>